HCG and Testosterone: Preserving Fertility
and Testicular Function on TRT

Testosterone replacement therapy is highly effective at restoring hormonal balance in men with low T — but it comes with a trade-off most men aren't told about upfront. When you introduce exogenous testosterone, your brain's hypothalamic-pituitary axis reads it as "enough testosterone" and stops signaling your testes to produce more. The result is a suppression of the LH (luteinizing hormone) signal that keeps your testes active and sperm production online. HCG (human chorionic gonadotropin) is the tool physicians use to address this directly.

How HCG Works: The LH Mimetic

HCG is a glycoprotein hormone that binds to the same receptor as LH (luteinizing hormone) — the LH/hCG receptor on testicular Leydig cells. When LH or HCG binds this receptor, Leydig cells produce testosterone and support the intratesticular environment needed for sperm production.

During TRT, LH is suppressed — often to near-zero — because your hypothalamus detects adequate (actually supraphysiologic) testosterone levels and stops the signaling cascade. Your testes, receiving no LH signal, essentially go dormant. HCG acts as a stand-in for LH: it binds the same receptor, stimulates Leydig cells to continue producing intratesticular testosterone, and maintains the hormonal environment the testes need to remain active.

The result is that the testes remain physiologically active even when LH is suppressed. This matters for testicular size, fertility, and — many men report — the subjective "feel" of hormonal wellbeing.

Testicular Atrophy: What It Is and Why It Matters

Testicular atrophy — a reduction in testicular volume — is a common consequence of TRT without HCG. When the testes go dormant due to LH suppression, they shrink. For many men this is mild (20–30% reduction in volume); for some it's more significant and cosmetically or psychologically distressing.

The atrophy itself is not medically dangerous in most cases — the primary concern is functional. Shrunken testes have impaired spermatogenesis and reduced capacity for hormone production. This becomes clinically important when a man on TRT wants to either have children or eventually discontinue TRT and restore natural testosterone production.

Adding HCG to a TRT protocol prevents the majority of testicular volume loss. Many men using HCG from the start of TRT report no appreciable change in testicular size throughout treatment.

Fertility Preservation: The Critical Consideration

Testosterone replacement therapy is not a contraceptive — but it is highly effective at suppressing sperm production. Exogenous testosterone dramatically reduces intratesticular testosterone concentrations (a different compartment from serum testosterone), and high intratesticular T is essential for spermatogenesis.

For men who want to maintain fertility while on TRT, HCG is the standard approach:

• HCG maintains intratesticular testosterone by stimulating Leydig cells directly
• High intratesticular T supports spermatogenesis in the Sertoli cells
• Sperm counts in men on TRT + HCG are typically much higher than in men on TRT alone
• Some men on high-dose TRT will still see reduced sperm counts even with HCG — FSH (follicle-stimulating hormone) is also suppressed, and FSH directly supports Sertoli cell function

For men actively trying to conceive, TRT + HCG alone may not be sufficient, and adding FSH (typically recombinant FSH or hMG) may be necessary. However, for men who want to preserve fertility potential while on TRT without actively trying to conceive, HCG provides meaningful protection.

HCG + TRT Protocols in Practice

There is no single universally established HCG protocol, and dosing is individualized. Common approaches include:

• 250–500 IU twice weekly: Most common protocol; maintains testicular stimulation without excessive HCG levels
• 500 IU three times weekly: Higher stimulation; may be appropriate for men with significant fertility concerns
• Monotherapy (HCG alone): For men who want testosterone restoration without fully suppressing the HPG axis; less effective than TRT for most men but fertility-preserving

HCG does stimulate testosterone production in the testes, which means your total testosterone will be higher than TRT alone. This also means HCG provides additional substrate for estrogen (aromatase) conversion — estrogen monitoring is particularly important when HCG is included in a protocol.

Compounded HCG: The Regulatory Story

HCG's regulatory status has been complicated in recent years. In 2020, the FDA discontinued the use of compounded HCG, requiring that all HCG be FDA-approved (brand-name products). However, FDA-approved HCG products (Pregnyl, Novarel) remain available with a prescription and are widely used in TRT protocols.

The practical implication: you should expect your HCG prescription to be filled with an FDA-approved product at your pharmacy rather than a compounded product from a specialty pharmacy. Insurance coverage for HCG in the context of TRT varies — it's more likely to be covered when prescribed for hypogonadism-related fertility preservation than for general wellness.

Some clinics have pivoted to using kisspeptin or enclomiphene as LH secretagogues in contexts where HCG isn't preferred. These are different compounds with different mechanisms — your physician will discuss which option is most appropriate for your situation.

Who Needs HCG on TRT?

Adding HCG to a TRT protocol is appropriate for men who:

• Want to have children now or in the near future
• Want to preserve fertility potential in case they want children later
• Are concerned about testicular atrophy for cosmetic or psychological reasons
• Report that their sense of wellbeing or libido feels incomplete on TRT alone (intratesticular hormones may contribute to subjective hormonal experience)
• Plan to eventually discontinue TRT and want to preserve the ability to recover natural production more readily

Not every man on TRT needs HCG. For men who are done having children and unconcerned about testicular size or future TRT discontinuation, the added complexity (and cost) of HCG may not be warranted. This is a conversation worth having with your physician based on your specific goals.

Our Approach at Revive

We discuss HCG with every man starting testosterone therapy — not as an upsell, but as a genuine part of informed consent. Understanding what TRT does to your endogenous production, and having a clear plan based on your fertility goals and personal priorities, is part of how we practice medicine. Schedule a consultation to discuss whether HCG belongs in your TRT protocol.